Search Results

2226 - 2250 of 83811
TitleWireDateTime
Aya Gold & Silver Announces Updated PEA for Boumadine: After-Tax NPV Doubles to $3.5B with 93% IRR Globe Newswire 09/09 07:00
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Alarum Technologies Ltd. (ALAR), Blaize Holdings, Inc. (BZAI), and HDFC Bank Limited (HDB) Announced by Holzer & Holzer, LLC Globe Newswire 09/09 07:00
Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026 Globe Newswire 09/09 07:00
CoinShares CEO Jean-Marie Mognetti to Attend Oppenheimer Fintech Leaders Conference in New York Globe Newswire 09/09 07:00
Honoring HR Leadership: American Express’s Monique Herena and HiBob’s Nirit Peled-Muntz Take Top Honors Globe Newswire 09/09 07:00
Xanadu and ASML Announce Collaboration to Advance Lithography for Photonic Quantum Hardware Globe Newswire 09/09 07:00
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Rackspace Technology, Inc. (RXT), Capricor Therapeutics, Inc. (CAPR), and Wise Group plc (WSE) Announced by Holzer & Holzer, LLC Globe Newswire 09/09 07:00
Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247 Globe Newswire 09/09 07:00
Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027 Globe Newswire 09/09 07:00
Lightbridge Secures Access to Idaho National Laboratory's Advanced Test Reactor Loop Facility to Irradiate Clad Lightbridge Fuel™ Rodlets Under Prototypic Commercial Reactor Conditions Globe Newswire 09/09 07:00
ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter Globe Newswire 09/09 07:00
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment Globe Newswire 09/09 07:00
Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation Globe Newswire 09/09 07:00
SunHydrogen CTO Details Path from Demonstrated Module Performance to Commercialization Globe Newswire 09/09 07:00
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026 Globe Newswire 09/09 07:00
Operative Launches Unified Platform to Transform Advertising & Broadcast Management Globe Newswire 09/09 07:00
Troilus Reports Updated Technical Report Following Completion of Basic Engineering, Delivering After-Tax US$3.2 Billion NPV5%, 22% IRR, and Cashflow of US$6.9 Billion at Base Case Gold Price of US $3,600/oz Globe Newswire 09/09 07:00
LifeStance Health Group Announces Launch of Secondary Public Offering Globe Newswire 09/09 07:00
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs Globe Newswire 09/09 06:55
Digital Substations Market Size, Share, Insights, Competitive Intelligence, Demand Globe Newswire 09/09 06:53
INV Legal Notice: BFA Law Notifies Innventure Investors that Lost Money of the Imminent October 27 Securities Fraud Class Action Deadline Globe Newswire 09/09 06:36
CDNL Legal Notice: BFA Law Notifies Cardinal Infrastructure Investors that Lost Money of the Ongoing Securities Fraud Investigation Globe Newswire 09/09 06:36
CCB Legal Notice: BFA Law Notifies Coastal Financial Investors that Lost Money of the Ongoing Securities Fraud Investigation Globe Newswire 09/09 06:36
GIL Legal Notice: BFA Law Notifies Gildan Investors that Lost Money of the Ongoing Securities Fraud Investigation Globe Newswire 09/09 06:36
RXT Legal Notice: BFA Law Notifies Rackspace Technology Investors that Lost Money of the Imminent September 28 Securities Fraud Class Action Deadline Globe Newswire 09/09 06:36
2226 - 2250 of 83811

News, Photo and Web Search

Search News by Ticker